Literature DB >> 10196766

Nisin A depletes intracellular ATP and acts in bactericidal manner against Mycobacterium smegmatis.

T J Montville1, H J Chung, M L Chikindas, Y Chen.   

Abstract

Nisin is a bacteriocin produced by many strains of Lactococcus lactis. This study examined the effect of nisin on Mycobacterium smegmatis, a non-pathogenic species of Mycobacterium. Nisin had a minimum inhibitory concentration of 8.0 micrograms ml-1 and a minimum inhibitory dose of 7.5 micrograms ml-1 against Myco. smegmatis. Treatment with 25.0 micrograms ml-1 nisin caused partial inhibition of Myco smegmatis; the survivors were nisin-sensitive when tested in a separate experiment. Mycobacterium smegmatis cells exposed to 50.0 micrograms ml-1 of nisin, lost their viability. the effect of nisin on the growth of Myco. smegmatis was both time- and concentration-dependent. Nisin (10.0 micrograms ml-1) caused 97.7 +/- 2.0% reduction in internal ATP and leakage of intracellular ATP out of Myco. smegmatis cells after several hours of treatment. These data suggest that nisin inhibits Myco. smegmatis by the same mechanism by which it inhibits other bacteria and warrants further investigation as a possible antitubercular agent.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10196766     DOI: 10.1046/j.1365-2672.1999.00511.x

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN: 0266-8254            Impact factor:   2.858


  8 in total

1.  Bovicin HC5, a lantibiotic produced by Streptococcus bovis HC5, catalyzes the efflux of intracellular potassium but not ATP.

Authors:  Hilário C Mantovani; James B Russell
Journal:  Antimicrob Agents Chemother       Date:  2008-03-17       Impact factor: 5.191

2.  Lantibiotics as prospective antimycobacterial agents.

Authors:  John Donaghy
Journal:  Bioeng Bugs       Date:  2010 Nov-Dec

Review 3.  Energy metabolism and drug efflux in Mycobacterium tuberculosis.

Authors:  Philippa A Black; Robin M Warren; Gail E Louw; Paul D van Helden; Thomas C Victor; Bavesh D Kana
Journal:  Antimicrob Agents Chemother       Date:  2014-03-10       Impact factor: 5.191

4.  Virgicin, a novel lanthipeptide from Virgibacillus sp. strain AK90 exhibits inhibitory activity against Gram-positive bacteria.

Authors:  Vasundhera Gupta; Shelley Sardul Singh; Chandni Sidhu; Vishakha Grover; Anil Kumar Pinnaka; Suresh Korpole
Journal:  World J Microbiol Biotechnol       Date:  2019-08-20       Impact factor: 3.312

Review 5.  Therapeutic Application of Lantibiotics and Other Lanthipeptides: Old and New Findings.

Authors:  Anton Du Preez van Staden; Winschau F van Zyl; Marla Trindade; Leon M T Dicks; Carine Smith
Journal:  Appl Environ Microbiol       Date:  2021-06-25       Impact factor: 4.792

Review 6.  Use of Bacteriocins and Bacteriocinogenic Beneficial Organisms in Food Products: Benefits, Challenges, Concerns.

Authors:  Svetoslav Dimitrov Todorov; Igor Popov; Richard Weeks; Michael Leonidas Chikindas
Journal:  Foods       Date:  2022-10-10

7.  Expanding the use of a fluorogenic method to determine activity and mode of action of Bacillus thuringiensis bacteriocins against Gram-positive and Gram-negative bacteria.

Authors:  Norma M de la Fuente-Salcido; J Eleazar Barboza-Corona; A N Espino Monzón; R D Pacheco Cano; N Balagurusamy; Dennis K Bideshi; Rubén Salcedo-Hernández
Journal:  ScientificWorldJournal       Date:  2012-08-01

8.  Lactic acid Bacteria isolated from European badgers (Meles meles) reduce the viability and survival of Bacillus Calmette-Guerin (BCG) vaccine and influence the immune response to BCG in a human macrophage model.

Authors:  Anna Stedman; Carlos Maluquer de Motes; Sandrine Lesellier; Deanna Dalley; Mark Chambers; Jorge Gutierrez-Merino
Journal:  BMC Microbiol       Date:  2018-07-13       Impact factor: 3.605

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.